
Opinion|Videos|April 15, 2025
The VISIBLE Study: Understanding Comorbidities in Psoriasis Across All Skin Tones
Author(s)Aaron Farberg, MD
An expert discusses how the VISIBLE study examined comorbidity burden in moderate to severe psoriasis across all skin tones, addressing disparities in research. It aimed to highlight unmet needs and improve understanding of disease impact in diverse populations.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is the key background of the VISIBLE study, which examined the burden of comorbidities in participants with moderate to severe psoriasis across all skin tones?
- What do you believe was the impetus for this study?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC
3
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
4
Jury Still Out on Testosterone Benefit to Menopause
5











































